Clinical Trial Update: Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of intravitreal fasudil and bevacizumab for diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (bevacizumab)
• fasudil (fasudil)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED